Skip to main content
Clinical Trials/NCT06666985
NCT06666985
Recruiting
Phase 4

Intrathecal Morphine for Postoperative Analgesia in Major Laparoscopic Abdominal Surgery (IMPACT-Scope): a Randomised, Sham-controlled, Blinded, Multicentre Clinical Trial

First Affiliated Hospital, Sun Yat-Sen University1 site in 1 country700 target enrollmentStarted: December 16, 2024Last updated:

Overview

Phase
Phase 4
Status
Recruiting
Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Enrollment
700
Locations
1
Primary Endpoint
Quality of recovery

Overview

Brief Summary

The goal of this clinical trial is to learn the clinical and cost effectiveness of intrathecal morphine (ITM) in addition to usual care as a postoperative pain relief strategy following major laparoscopic abdominal surgery compared with current usual care. The main questions it aims to answer are:

An enhanced analgesic technique, consisting of ITM in addition to usual care , improves the postoperative quality of recovery at day 1 after surgery by at least 6 points on the 15-item quality of recovery questionnaire (QoR-15) compared to usual care alone, in patients undergoing major laparoscopic abdominal surgery?

Researchers will compare ITM + Usual care to Sham ITM + Usual Care (The sham ITM mimics the ITM procedure, but the dura is not breached) to see if ITM works to postoperative pain relief.

Participants will:

Receive ITM + Usual care or Sham ITM + Usual care on surgery day Have interview with outcome assessors and complete the CRFs on the day of surgery, postoperative day 1, day 2, day 3 and up to postoperative day 30

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

ITM + Usual Care

Experimental

Intervention: ITM + Usual Care (Drug)

Sham ITM + Usual Care

Sham Comparator

Intervention: Sham ITM + Usual Care (Drug)

Outcomes

Primary Outcomes

Quality of recovery

Time Frame: Postoperative day 1

Quality of recovery is measured using the 15-item Quality of Recovery Questionnaire (QoR-15)

Secondary Outcomes

  • Quality of recovery(Postoperative day 2 , Postoperative day 3 (or at discharge, if earlier))
  • Quality of life(Postoperative day 1, Postoperative day 2, Postoperative day 3 (or at discharge, if earlier) and Postoperative day 30)
  • Pain scores in the post-anaesthesia recovery unit(Day of surgery)
  • Worst pain score(Postoperative day 1, Postoperative day 2, and Postoperative day 3 (or at discharge, if earlier))
  • Anaesthesia-related discomfort (nausea and/or vomiting, drowsiness, shivering, pruritus)(Postoperative day 1, Postoperative day 2, Postoperative day 3 (or at discharge, if earlier))
  • Patient satisfaction(Postoperative day 1, Postoperative day 2, Postoperative day 3 (or at discharge, if earlier))
  • Time in minutes to tracheal extubation from the end of anaesthesia(From end of anesthesia to tracheal extubation on day of surgery or from end of anesthesia to discharge day (for ICU patients) up to 48 hours)
  • Number of pain management visits(Postoperative day 1, Postoperative day 2, Postoperative day 3(or at discharge, if earlier), day of discharge and Postoperative day 30)
  • Postoperative pulmonary complications(Postoperative day 1, Postoperative day 2 and Postoperative day 3 (or at discharge, if earlier))
  • Respiratory depression(Day of surgery, Postoperative day 1, Postoperative day 2, Postoperative day 3 (or at discharge, if earlier))
  • Total opioid consumption(During operation and up to Postoperative day 30)
  • Postoperative mobilisation(Postoperative day 1,Postoperative day 2, Postoperative day 3 (or at discharge, if earlier))
  • Doses of antiemetics administered postoperatively (number of administration)(Day of Surgery, Postoperative day 1, Postoperative day 2, Postoperative day 3 (or at discharge, if earlier))
  • Length of Hospital Stay(1 Day after surgery)
  • Days at Home and well After Surgery (DAH-30)(Postoperative day 30)
  • Mortality(Postoperative day 30)

Investigators

Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Feng Xia

Professor

First Affiliated Hospital, Sun Yat-Sen University

Study Sites (1)

Loading locations...

Similar Trials